Insurer denial rates, appeal outcomes by treatment and condition, and appeal rights lookups.
Dedotto dai trasporti dichiarati da questo annuncio (streamable-http). Un client che non compare qui non è escluso — semplicemente Forge non è in grado di confermarlo.
La verifica conferma l’identità del publisher (la proprietà del repo), non la sicurezza del codice. L’analisi di sicurezza copre i CVE noti e gli script di installazione sospetti.
Letto da un vero handshake MCP initialize → tools/list verso l’endpoint dichiarato. Nessuno strumento è stato invocato — tools/list è la chiamata di introspezione in sola lettura che il protocollo prevede a questo scopo. Riflette ciò che il server annunciava in quel momento; un endpoint ospitato non è vincolato ad alcuna versione e può cambiare senza preavviso.
https://www.coverage-rights.com/api/mcp9 strumenti · 246 mslist_insurersList tracked U.S. health insurers with whether verified CMS-0057-F prior-authorization metrics are available for each.List tracked U.S. health insurers with whether verified CMS-0057-F prior-authorization metrics are available for each.
Per questo strumento non è stato pubblicato alcuno schema di input.
get_insurer_metricsGet an insurer's verified CY2025 prior-authorization metrics (denial rate, appeal overturn rate, decision times) from its own CMS-0057-F disclosure, plus contract/plan-level rows where collected. Includes source URLs and scope notes.Get an insurer's verified CY2025 prior-authorization metrics (denial rate, appeal overturn rate, decision times) from its own CMS-0057-F disclosure, plus contract/plan-level rows where collected. Includes source URLs and scope notes.
| Parametro | Tipo | Descrizione |
|---|---|---|
| slug* | string | Insurer slug from list_insurers, e.g. 'unitedhealthcare' |
rank_denial_ratesInsurer prior-authorization denial rates (CY2025), ranked only within compatible reporting cohorts. Each row includes its cohort, rank within that cohort, exact source scope, calculation method, and source link. Never compare ranks across cohorts.Insurer prior-authorization denial rates (CY2025), ranked only within compatible reporting cohorts. Each row includes its cohort, rank within that cohort, exact source scope, calculation method, and source link. Never compare ranks across cohorts.
Per questo strumento non è stato pubblicato alcuno schema di input.
get_treatment_outcomesExternal-review outcomes for a treatment: how often insurer denials of this treatment/drug/procedure were overturned by independent reviewers (42,749 published CA IMR decisions, 2001–2026). Accepts a category slug (e.g. 'pharmacy') or specific treatment slug (e.g. 'zepbound', 'speech-therapy').External-review outcomes for a treatment: how often insurer denials of this treatment/drug/procedure were overturned by independent reviewers (42,749 published CA IMR decisions, 2001–2026). Accepts a category slug (e.g. 'pharmacy') or specific treatment slug (e.g. 'zepbound', 'speech-therapy').
| Parametro | Tipo | Descrizione |
|---|---|---|
| slug* | string | Treatment slug, e.g. 'zepbound', 'pharmacy', 'speech-therapy'. Use search_outcomes to find slugs. |
get_condition_outcomesExternal-review outcomes for a medical condition: how often insurance denials involving this condition were overturned, plus the most-fought treatments for it.External-review outcomes for a medical condition: how often insurance denials involving this condition were overturned, plus the most-fought treatments for it.
| Parametro | Tipo | Descrizione |
|---|---|---|
| slug* | string | Condition slug, e.g. 'obesity', 'autism', 'hepatitis-c' |
search_outcomesSearch treatments (categories + specific drugs/procedures) and conditions by name. Returns slugs for get_treatment_outcomes / get_condition_outcomes plus headline overturn rates.Search treatments (categories + specific drugs/procedures) and conditions by name. Returns slugs for get_treatment_outcomes / get_condition_outcomes plus headline overturn rates.
| Parametro | Tipo | Descrizione |
|---|---|---|
| query* | string | Search text, e.g. 'wegovy', 'back pain', 'imaging' |
| limit | integer | Max results per type (default 10) |
get_appeal_rightsDeterministically resolve the governing appeal route, missing facts, filing recipient, deadlines, current external-review status, and verified grounds. Distinguishes Original Medicare, Medicare Advantage medical benefits, Part D pharmacy benefits, employer funding/governance, ACA, Medicaid, FEHB, T…Deterministically resolve the governing appeal route, missing facts, filing recipient, deadlines, current external-review status, and verified grounds. Distinguishes Original Medicare, Medicare Advantage medical benefits, Part D pharmacy benefits, employer funding/governance, ACA, Medicaid, FEHB, T…
| Parametro | Tipo | Descrizione |
|---|---|---|
| program* | string | Plan type |
| denial_reason* | string | Denial reason category. Use 'prescription-drug' for medication denials — formulary exclusion, step therapy, quantity limits, or drug prior authorization — whic… |
| state | string | Two-letter state code, e.g. 'ca' |
| insurer_slug | string | Insurer slug for insurer-specific stats |
| employer_type | string | Required to resolve job-based coverage |
| funding_status | string | Required to resolve job-based state versus federal governance |
| drug_channel | string | For a drug denial, whether the medical or pharmacy benefit applies |
| regulatory_marker | string | — |
| regulatory_state_basis | string | — |
| appeal_stage | string | — |
| current_status | string | — |
get_drug_playbookDrug-specific denial patterns and appeal strategy for the medications plans fight hardest over: GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic, Saxenda) and IBD biologics (Humira, Skyrizi, Stelara, Entyvio, Remicade, Rinvoq). Returns FDA-approved indications stated conservatively, why plans deny that…Drug-specific denial patterns and appeal strategy for the medications plans fight hardest over: GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic, Saxenda) and IBD biologics (Humira, Skyrizi, Stelara, Entyvio, Remicade, Rinvoq). Returns FDA-approved indications stated conservatively, why plans deny that…
| Parametro | Tipo | Descrizione |
|---|---|---|
| drug* | string | Brand or generic drug name, e.g. 'Zepbound', 'ustekinumab' |
get_state_external_reviewHow a state's external review process works: filing deadline, regulator contact, and key facts. Verified detail currently covers 10 states (CA, TX, FL, NY, PA, IL, OH, GA, NC, MI); other states return the covered list.How a state's external review process works: filing deadline, regulator contact, and key facts. Verified detail currently covers 10 states (CA, TX, FL, NY, PA, IL, OH, GA, NC, MI); other states return the covered list.
| Parametro | Tipo | Descrizione |
|---|---|---|
| state* | string | Two-letter state code, e.g. 'ca', 'ny', 'fl' |
9 strumenti su 9 hanno pubblicato una descrizione.
I nomi e le descrizioni degli strumenti sono scritti dal publisher e mostrati alla lettera come testo inerte. Sono le stringhe che un client MCP passa a un modello, quindi Forge vi cerca schemi di prompt injection — ogni rilievo compare insieme all’analisi di sicurezza qui sopra. «Privilegiato» è una corrispondenza di parola chiave sul nome dello strumento, non una verifica di ciò che fa: un nome innocuo può comunque fare qualsiasi cosa.
Insurer denial rates, appeal outcomes by treatment and condition, and appeal rights lookups.
I nomi collegati aprono l’indice Forge di tutte le voci osservate esporre quello strumento. Sfoglia tutti gli strumenti indicizzati.
Questa voce non pubblica alcun pacchetto npm, quindi Forge non ha un albero delle dipendenze per essa. È una lacuna di copertura, non l'affermazione che non abbia dipendenze.